Overview
Neeuro is a Singapore-based neurotechnology company that develops EEG-based cognitive training and monitoring platforms for healthcare and education. Their SenzeBand EEG headset and Memorie brain training app target cognitive health in aging populations and children with learning challenges.
Neeuro is a Singapore-based neurotechnology company specializing in EEG-based cognitive training and monitoring solutions that bridge healthcare and education. The company's core technology centers on the SenzeBand, a consumer-grade EEG headset that captures brain activity with ease of use comparable to commercial wearables. Combined with their Memorie brain training application, Neeuro enables objective measurement and improvement of cognitive function through scientifically-designed games and exercises, making neurotechnology accessible beyond clinical settings.
Since securing Series A funding of $5 million, Neeuro has established itself as a notable player in the growing cognitive health market with applications targeting two critical demographics: aging populations concerned with cognitive decline and children with learning challenges. The company has advanced beyond proof-of-concept to develop commercially viable products that integrate EEG monitoring with personalized cognitive interventions, positioning themselves at the intersection of preventive healthcare and educational technology.
Neeuro's significance to the neurotech industry lies in democratizing access to brain-computer interface technology for everyday cognitive wellness rather than purely clinical or research applications. By combining practical EEG hardware with evidence-based cognitive training software, they demonstrate a viable commercial model for neurotechnology that serves large, underserved populations while contributing to the normalization of brain monitoring as a standard health metric alongside traditional vital signs.
More in Brain-Computer Interfaces
Latest industry news
Synchron Closes $275M Series D to Accelerate Stentrode BCI Commercialization
2026-06-15 · Funding
MIT Researchers Demonstrate Real-Time Emotion Decoding via Non-Invasive EEG with 94% Accuracy
2026-06-13 · Research
Synchron Launches Stentrode Home Edition, Expanding BCI Access Beyond Clinical Settings
2026-06-11 · Product
Synchron Reaches 100-Patient Milestone as Stentrode BCI Moves Toward Pivotal Trial
2026-06-09 · Industry
Company details
Category
🧠 Brain-Computer Interfaces
Location
Singapore, Singapore
Funding
Series A · $5M
Website
neeuro.comListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →